Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence (NCT05887297) | Clinical Trial Compass
CompletedNot Applicable
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence
United Kingdom35 participantsStarted 2023-03-23
Plain-language summary
The aim of this study is to investigate the impact of cognitive behavioural therapy for insomnia on adherence to endocrine therapy medication in breast cancer survivors.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosed with breast cancer
* Aged 18 or over
* Currently prescribed endocrine therapy medication
* Experience symptoms of insomnia
* Self-reported nonadherent to ET medication (e.g. forgetting to take, or deliberately taking a break from medication)
* Proficient in English language
* Access to videoconferencing
Exclusion Criteria:
* Undertaking shift work (i.e., irregular or night shifts)
* Pregnancy or breastfeeding
* Other unstable physical or mental health problem (including substance misuse)
* Received CBT-I within past 12 months
* Received chemotherapy or radiotherapy within past 4 weeks